FIELD: ophthalmology. SUBSTANCE: method of treating intraocular and conjunctival melanoma consists in intratumoral injection of recombinant PNO-alpha. When tumor is not completely destroyed, brachiotherapy is additionally performed. EFFECT: enabled reduction of tumor up to the full regression preserving functionality of eye. 2 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 1998 |
|
RU2146823C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 1999 |
|
RU2157998C1 |
METHOD OF REVEALING LATENT METASTATIC SPREAD IN PATIENTS WITH UVEAL MELANOMA | 1998 |
|
RU2147373C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 2001 |
|
RU2192812C1 |
METHOD OF ORGAN PRESERVATION TREATMENT OF UVEAL MELANOMA | 2017 |
|
RU2655831C1 |
METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF LEIOMYOMA AND IRIS MELANOMA | 2001 |
|
RU2199124C1 |
Authors
Dates
2001-06-20—Published
2000-02-22—Filed